Cambridge Investment Research Advisors’s iShares iBonds Dec 2030 Term Corporate ETF IBDV Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$8.62M Buy
393,979
+12,998
+3% +$287K 0.02% 677
2025
Q4
$8.41M Buy
380,981
+15,251
+4% +$337K 0.02% 656
2025
Q3
$8.1M Buy
365,730
+9,579
+3% +$211K 0.02% 668
2025
Q2
$7.83M Buy
356,151
+30,117
+9% +$652K 0.02% 648
2025
Q1
$7.08M Buy
326,034
+48,582
+18% +$1.04M 0.02% 638
2024
Q4
$5.93M Buy
277,452
+27,848
+11% +$602K 0.02% 712
2024
Q3
$5.53M Buy
249,604
+5,297
+2% +$116K 0.02% 749
2024
Q2
$5.19M Sell
244,307
-216,935
-47% -$4.58M 0.02% 738
2024
Q1
$9.87M Buy
461,242
+447,429
+3,239% +$9.57M 0.04% 466
2023
Q4
$299K Buy
13,813
+873
+7% +$18.1K ﹤0.01% 2597
2023
Q3
$264K Buy
12,940
+1,276
+11% +$26.6K ﹤0.01% 2593
2023
Q2
$247K Sell
11,664
-838
-7% -$17.9K ﹤0.01% 2698
2023
Q1
$269K Buy
12,502
+891
+8% +$18.9K ﹤0.01% 2583
2022
Q4
$242K Buy
+11,611
New +$239K ﹤0.01% 2602

Other funds holding IBDV

Cambridge Investment Research Advisors's IBDV Position: Q1 2026 in Review

Cambridge Investment Research Advisors increased its iShares iBonds Dec 2030 Term Corporate ETF (IBDV) stake by 3.4% in Q1 2026, buying an estimated $287K and bringing the position to 393,979 shares worth $8.62M. The position accounts for 0.02% of the portfolio, ranked #677.

Cambridge Investment Research Advisors first reported a position in IBDV in Q4 2022 and has held it in 14 quarters since. The position peaked at $9.87M in Q1 2024. 335 funds tracked by Wall St. Rank hold IBDV as of Q1 2026.

  • Cambridge Investment Research Advisors held 393,979 shares of iShares iBonds Dec 2030 Term Corporate ETF worth $8.62M as of Q1 2026.
  • Cambridge Investment Research Advisors bought 12,998 iShares iBonds Dec 2030 Term Corporate ETF shares in Q1 2026, an estimated $287K.
  • iShares iBonds Dec 2030 Term Corporate ETF made up 0.02% of Cambridge Investment Research Advisors's portfolio in Q1 2026, its #677 holding.
  • Cambridge Investment Research Advisors first reported a position in iShares iBonds Dec 2030 Term Corporate ETF in Q4 2022 and has held it in 14 quarters since.
  • Cambridge Investment Research Advisors's iShares iBonds Dec 2030 Term Corporate ETF position peaked at $9.87M in Q1 2024.
  • 335 funds tracked by Wall St. Rank held iShares iBonds Dec 2030 Term Corporate ETF as of Q1 2026.

Based on Cambridge Investment Research Advisors's 13F filing for Q1 2026, filed 30 Apr 2026.